| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ridhima Vij, Alan Prossin, Mallika Tripathy, Hosu Kim, Hyeonggeun Park, Thanh Cheng, Djamchid Lotfi, Donna Chan. Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report. Frontiers in neurology. vol 14. 2023-10-16. PMID:37840944. |
parkinson's disease (pd) is a neurodegenerative disease that involves the loss of dopaminergic neurons in the substantia nigra pars compacta of the basal ganglia. |
2023-10-16 |
2023-11-08 |
Not clear |
| Yalan Chen, Junxin Kuang, Yimei Niu, Hongyao Zhu, Xiaoxia Chen, Kwok-Fai So, Anding Xu, Lingling Sh. Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons. Neural regeneration research. vol 19. issue 4. 2023-10-16. PMID:37843228. |
midbrain dopaminergic neurons play an important role in the etiology of neurodevelopmental and neurodegenerative diseases. |
2023-10-16 |
2023-11-08 |
human |
| Amin A Hafi. The neuroprotective effect of vitamin D in Parkinson's disease: association or causation. Nutritional neuroscience. 2023-09-21. PMID:37731327. |
parkinson's disease (pd) is a chronic neurodegenerative disease (ndd) due to the degeneration of dopaminergic neurons (dns) in the substantia nigra (sn). |
2023-09-21 |
2023-10-07 |
Not clear |
| Furkan Eker, Ecem Bolat, Burcu Pekdemir, Hatice Duman, Sercan Kara. Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment. Frontiers in aging neuroscience. vol 15. 2023-09-21. PMID:37731953. |
parkinson's disease (pd) is the second-most common neurodegenerative disease and is largely caused by the death of dopaminergic (da) cells. |
2023-09-21 |
2023-10-07 |
Not clear |
| Derya Cansiz, Ismail Unal, Merih Beler, Unsal Veli Ustundag, Esin Ak, Ebru Emekli-Alturfan, Ahmet Ata Alturfa. The Effect of Acetic Acid-Induced Pain in Parkinson's Disease Model in Zebrafish. Neurotoxicology. 2023-09-08. PMID:37683694. |
parkinson's disease (pd) is the second most common neurodegenerative disease caused by the degeneration of dopaminergic neurons and the accumulation of lewy bodies. |
2023-09-08 |
2023-10-07 |
zebrafish |
| Eun-Jin Heo, Youngsun Lee, Min Hyung Seo, Sujung Ye. Association between SGK1 and α-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model. Neuroscience letters. 2023-08-27. PMID:37634811. |
parkinson's disease (pd) is a neurodegenerative disease caused by loss of dopaminergic neurons in the substantia nigra and it is known to involve the accumulation of α-synuclein (α-syn), which is a neuroprotein that promotes degeneration of dopaminergic neurons. |
2023-08-27 |
2023-09-07 |
mouse |
| Christine Tara Peterson, Stanislav N Iablokov, Dmitry A Rodionov, Scott N Peterso. Personalized Response of Parkinson's Disease Gut Microbiota to Nootropic Medicinal Herbs In Vitro: A Proof of Concept. Microorganisms. vol 11. issue 8. 2023-08-26. PMID:37630539. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the loss of dopaminergic neurons. |
2023-08-26 |
2023-09-07 |
human |
| Saud A Alnaaim, Hayder M Al-Kuraishy, Athanasios Alexiou, Marios Papadakis, Hebatallah M Saad, Gaber El-Saber Batih. Role of Brain Liver X Receptor in Parkinson's Disease: Hidden Treasure and Emerging Opportunities. Molecular neurobiology. 2023-08-22. PMID:37606719. |
parkinson's disease (pd) is a neurodegenerative disease due to the degeneration of dopaminergic neurons (dns) in the substantia nigra (sn). |
2023-08-22 |
2023-09-07 |
Not clear |
| Haiyang Yu, Qing Chang, Tong Sun, Xin He, Lulu Wen, Jing An, Juan Feng, Yuhong Zha. Metabolic reprogramming and polarization of microglia in Parkinson's disease: Role of inflammasome and iron. Ageing research reviews. 2023-08-12. PMID:37572760. |
parkinson's disease (pd) is a slowly progressive neurodegenerative disease characterized by α-synuclein aggregation and dopaminergic neuronal death. |
2023-08-12 |
2023-08-16 |
Not clear |
| Tuba Oz, Ajeet Kaushik, Małgorzata Kujawsk. Neural stem cells for Parkinson's disease management: Challenges, nanobased support, and prospects. World journal of stem cells. vol 15. issue 7. 2023-08-07. PMID:37545757. |
parkinson's disease (pd), characterized by loss of nigrostriatal dopaminergic neurons, is one of the most predominant neurodegenerative diseases affecting the elderly population worldwide. |
2023-08-07 |
2023-08-14 |
Not clear |
| Can-Tang Zhang, Deng-Li Qin, Xia-Yin Cao, Jia-Shuo Kan, Xin-Xing Huang, Dian-Shuai Gao, Jin Ga. Dephosphorylation of Six2Y129 protects tyrosine hydroxylase-positive cells in SNpc by regulating TEA domain 1 expression. iScience. vol 26. issue 7. 2023-08-03. PMID:37534182. |
parkinson's disease (pd) is a neurodegenerative disease characterized by selective loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snpc). |
2023-08-03 |
2023-08-14 |
Not clear |
| Zhongting Zhao, Zheng Li, Fangning Du, Yixin Wang, Yue Wu, Kah-Leong Lim, Lin Li, Naidi Yang, Changmin Yu, Chengwu Zhan. Linking Heat Shock Protein 70 and Parkin in Parkinson's Disease. Molecular neurobiology. 2023-08-01. PMID:37526897. |
parkinson's disease (pd) is a neurodegenerative disease that affects millions of elderly people worldwide and is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2023-08-01 |
2023-08-14 |
Not clear |
| Sri Jayanti, Camilla Dalla Verde, Claudio Tiribelli, Silvia Gazzi. Inflammation, Dopaminergic Brain and Bilirubin. International journal of molecular sciences. vol 24. issue 14. 2023-07-29. PMID:37511235. |
dopaminergic neurons (dopan) are susceptible to stressors, and inflammation is a recognized risk for neuronal malfunctioning and cell death in major neurodegenerative diseases. |
2023-07-29 |
2023-08-14 |
Not clear |
| Qin Li, Shuai Li, Jiankang Fang, Chao Yang, Xia Zhao, Qing Wang, Wenshu Zhou, Wenhua Zhen. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway. Molecules (Basel, Switzerland). vol 28. issue 14. 2023-07-29. PMID:37513399. |
parkinson's disease (pd) is an age-related, progressive neurodegenerative disease characterized by the gradual and massive loss of dopaminergic neurons in the substantia nigra pars compacta (snc). |
2023-07-29 |
2023-08-14 |
Not clear |
| Marika Alborghetti, Edoardo Bianchini, Lanfranco De Carolis, Silvia Galli, Francesco E Pontieri, Domiziana Rinald. Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings. Neural regeneration research. vol 19. issue 1. 2023-07-25. PMID:37488838. |
preclinical studies indicate that type-b monoamine oxidase inhibitors hold a strong neuroprotective potential in parkinson's disease and other neurodegenerative diseases for reducing oxidative stress and stimulating the production and release of neurotrophic factors, particularly glial cell line-derived neurotrophic factor, which support dopaminergic neurons. |
2023-07-25 |
2023-08-14 |
Not clear |
| Ricardo J Ramírez-Carreto, Víctor J Zaldívar-Machorro, Dafne J Pérez-Ramírez, Blanca E Rodríguez-López, Claudia Meza, Esperanza García, Abel Santamaría, Anahí Chavarrí. Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice. Molecular neurobiology. 2023-07-22. PMID:37480498. |
parkinson's disease (pd) is the second most frequent neurodegenerative disease associated with motor dysfunction secondary to the loss of dopaminergic neurons in the nigrostriatal axis. |
2023-07-22 |
2023-08-14 |
mouse |
| Tao Pan, Qi Xiao, Hui-Jie Fan, Lei Xu, Shao-Chen Qin, Li-Xia Yang, Xiao-Ming Jin, Bao-Guo Xiao, Bo Zhang, Cun-Gen Ma, Zhi Cha. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation. Metabolic brain disease. 2023-07-20. PMID:37470879. |
parkinson disease (pd) is an age-related neurodegenerative disease, which is associated with the loss of dopaminergic neurons (da neurons) in the substantia nigra pars compacta (snpc), and neuroinflammation may lead to the occurrence of pd. |
2023-07-20 |
2023-08-14 |
mouse |
| Katherine S Morton, Jessica H Hartman, Nathan Heffernan, Ian T Ryde, Isabel W Kenny-Ganzert, Lingfeng Meng, David R Sherwood, Joel N Meye. Chronic high-sugar diet in adulthood protects bioRxiv : the preprint server for biology. 2023-07-03. PMID:37398434. |
parkinson's disease (pd) is the second most prevalent neurodegenerative disease and is characterized by the progressive death of dopaminergic neurons in the brain. |
2023-07-03 |
2023-08-14 |
Not clear |
| Sheikh Azimullah, Mohamed Fizur Nagoor Meeran, Khatija Ayoob, Seenipandi Arunachalam, Shreesh Ojha, Rami Beira. Tannic Acid Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Inhibiting Inflammation, Oxidative Stress, Apoptosis, and Glutamate Toxicity in Rats. International journal of molecular sciences. vol 24. issue 12. 2023-06-28. PMID:37373023. |
parkinson's disease (pd), a movement disorder, is a neurodegenerative disease characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (snpc) region of the brain. |
2023-06-28 |
2023-08-14 |
human |
| Mjid Oukhrib, Lahcen Tamegart, Abdeslam Assafi, Lamia Hejji, Abdelmonaim Azzouz, Luis Pérez Villarejo, Mohammed Haida, Chraa Mohamed, Halima Gamran. Effects of graphene oxide nanoparticles administration against reserpine-induced neurobehavioral damage and oxidative stress in an animal model of Parkinson's disease. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2023-06-25. PMID:37356558. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by the degeneration of substantia nigra dopaminergic neurons. |
2023-06-25 |
2023-08-14 |
mouse |